Determinants of mortality in non-neutropenic ICU patients with candidaemiaReportar como inadecuado

Determinants of mortality in non-neutropenic ICU patients with candidaemia - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Critical Care

, 13:R115

First Online: 13 July 2009Received: 10 June 2009Accepted: 13 July 2009


IntroductionCandidaemia in critically-ill intensive care unit ICU patients is associated with high crude mortality. Determinants of mortality – particularly those amenable to potential modification – are incompletely defined.

MethodsA nationwide prospective clinical and microbiological cohort study of all episodes of ICU-acquired candidaemia occurring in non-neutropenic adults was undertaken in Australian ICUs between 2001 and 2004. Multivariate Cox regression analyses were performed to determine independently significant variables associated with mortality.

Results183 episodes of ICU-acquired candidaemia occurred in 183 patients during the study period. Of the 179 with microbiological data, Candida albicans accounted for 111 62% episodes and Candida glabrata, 32 18%. Outcome data were available for 173: crude hospital mortality at 30 days was 56%. Host factors older age, ICU admission diagnosis, mechanical ventilation and ICU admission diagnosis and failure to receive systemic antifungal therapy were significantly associated with mortality on multivariate analysis. Among the subset who received initial fluconazole therapy n = 93, the crude mortality was 52%. Host factors increasing age and haemodialysis receipt, but not organism- Candida species, fluconazole MIC, pharmacokinetic- fluconazole dose, time to initiation, or pharmacodynamic-related parameters fluconazole dose:MIC ratio were associated with mortality. Process of care measures advocated in recent guidelines were implemented inconsistently: follow-up blood cultures were obtained in 68% of patients, central venous catheters removed within five days in 80% and ophthalmological examination performed in 36%.

ConclusionsCrude mortality remains high in Australian ICU patients with candidaemia and is overwhelmingly related to host factors but not treatment variables the time to initiation of antifungals or fluconazole pharmacokinetic and pharmacodynamic factors. The role and timing of early antifungal intervention in critically-ill ICU patients requires further investigation.

AbbreviationsICUintensive care unit

IDSAInfectious Diseases Society of America

IQRinterquartile range

MICminimum inhibitory concentration.

Electronic supplementary materialThe online version of this article doi:10.1186-cc7964 contains supplementary material, which is available to authorized users.

Deborah JE Marriott, E Geoffrey Playford contributed equally to this work.

Download fulltext PDF

Autor: Deborah JE Marriott - E Geoffrey Playford - Sharon Chen - Monica Slavin - Quoc Nguyen - David Ellis - Tania C Sorrell -


Documentos relacionados